scispace - formally typeset
G

Gordon C. Sharp

Researcher at Stanford University

Publications -  16
Citations -  6421

Gordon C. Sharp is an academic researcher from Stanford University. The author has contributed to research in topics: Antigen & Lupus erythematosus. The author has an hindex of 15, co-authored 16 publications receiving 6298 citations.

Papers
More filters
Journal Article

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

TL;DR: Proposed classification criteria for systemic sclerosis had a 97% sensitivity for definite systemic sclerosis and 98% specificity when applied to the case and comparison patients included in this study.
Journal ArticleDOI

Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)

TL;DR: The detection of antibody to ENA with a well defined specificity allows recognition of an apparently distinct mixed connective tissue disease syndrome which is characterized by an excellent response to corticosteroid therapy and a favorable prognosis.
Journal ArticleDOI

Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.

TL;DR: It is likely that the patient with hemagglutinating antibodies to ribonuclease-resistant extractable nuclear antigen has mixed connective-tissue disease, if the serum contains only ribonucleoprotein antibody in high titer.
Journal ArticleDOI

Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders

TL;DR: The prevalence of scleroderma-type capillary abnormalities, as observed by in vivo microscopy, was determined in 173 patients from three rheumatic disease centers, finding enlarged and deformed capillary loops surrounded by relatively avascular areas, most prominently in the nail-folds were found in 82% of patients with sclerodma and in 54% with mixed connective tissue disease.
Journal ArticleDOI

Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy

TL;DR: Results yield significant correlations among the pattern of autoimmune reactivity, the clinical form of the rheumatic disease, and responsiveness to treatment, which implicate the qualitative nature of the patient's immune response as a conditioning factor in the type of disease.